The Corporate Reflection
Linda’s position as a research coordinator for Morrison Pharmaceuticals had given her insight into the systematic approaches used to develop treatments for behavioral disorders in adolescents. The company’s investment in pediatric mental health research reflected growing recognition that early intervention could prevent the kind of escalating antisocial behavior that Marcus was displaying.
Her work with clinical trials for experimental treatments designed to address conduct disorders and oppositional defiant behavior provided hope that science might offer solutions where traditional parenting had failed. The medical facility where these trials were conducted specialized in adolescent psychiatry, and Linda had secured priority access to the most innovative therapeutic approaches available.
The insurance coverage provided by her employer included comprehensive mental health benefits, and Linda had utilized every available resource in her attempt to understand and address Marcus’s behavior. Family therapy sessions, individual counseling, group intervention programs, and even residential treatment consultations had become regular features of their lives.
But despite the best efforts of healthcare professionals and the most advanced therapeutic interventions, Marcus’s behavior continued to escalate. The pharmaceutical approaches that worked for other adolescents seemed to have no effect on her son, who treated every form of intervention as an amusing game rather than a serious attempt to help him.
